Alzex Neuropharma Market Cap

Alzex Neuropharma has a market cap or net worth of $753.00 as of April 29, 2026. Its market cap has decreased by -99.91% in one year.

Market Cap

753.00

Enterprise Value

n/a

Revenue

4.73M

Ranking

n/a

PE Ratio

0.02

Stock Price

$0.00

Market Cap Chart

Since July 14, 2008, Alzex Neuropharma's market cap has decreased from 60.00K to 753.00, a decrease of -98.75%. That is a compound annual growth rate of -21.86%.

Market Cap History

Date	Market Cap	% Change
Apr 10, 2026	753.00	150.17%
Dec 30, 2025	301.00	-99.90%
Dec 31, 2024	298.04K	-1.00%
Dec 14, 2023	301.05K	-9.09%
Dec 23, 2022	331.16K	-51.11%
Dec 28, 2021	677.37K	857,331.65%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 22, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
RegeneRx Biopharmaceuticals	754.00
Pathfinder Cell Therapy	667.00
U.S. Stem Cell	662.00
eFFECTOR Therapeutics	941.00
Adynxx	581.00
GlobeImmune	575.00
Mera Pharmaceuticals	537.00
Tetra Bio-Pharma	516.00

Market Cap Rankings